These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8907547)

  • 21. The correlation between expression of apoptosis-related proteins and myocardial functional reserve evaluated by dobutamine stress echocardiography in patients with dilated cardiomyopathy.
    Ho YL; Chen CL; Hsu RB; Lin LC; Huang PJ
    J Am Soc Echocardiogr; 2003 Sep; 16(9):931-6. PubMed ID: 12931104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased myocardial expression of dystrophin and titin mRNA and protein in dilated cardiomyopathy: possibly an adverse effect of TNF-alpha.
    Ahmad S; Rai TS; Khullar M; Bahl A; Saikia UN; Thungapathra M; Kumar RM; Mahajan R; Talwar KK
    J Clin Immunol; 2010 Jul; 30(4):520-30. PubMed ID: 20373002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovering novel targets for autoantibodies in dilated cardiomyopathy.
    Buse C; Altmann F; Amann B; Hauck SM; Poulsen Nautrup C; Ueffing M; Stangassinger M; Deeg CA
    Electrophoresis; 2008 Mar; 29(6):1325-32. PubMed ID: 18288668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
    Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
    Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
    Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in expression of P2X1 receptors in the atria of patients suffering from dilated cardiomyopathy.
    Berry DA; Barden JA; Balcar VJ; Keogh A; dos Remedios CG
    Electrophoresis; 1999 Jul; 20(10):2059-64. PubMed ID: 10451115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspects of molecular mechanisms in myocardial hypertrophy, particular morphological changes and cell bioenergetic characteristics in patients with dilated cardiomyopathy.
    Branishte T; Minciuna V; Braniste A
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):851-6. PubMed ID: 24502060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
    Wang Z; Liao Y; Dong J; Li S; Wang J; Fu ML
    Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular evaluation of five cardiac genes in Doberman Pinschers with dilated cardiomyopathy.
    Meurs KM; Hendrix KP; Norgard MM
    Am J Vet Res; 2008 Aug; 69(8):1050-3. PubMed ID: 18672969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Familial dilated cardiomyopathy].
    Osterziel KJ; Hassfeld S; Geier C; Perrot A
    Herz; 2005 Sep; 30(6):529-34. PubMed ID: 16170685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): lack of correlation between phospholipase C activation and the phenotype.
    Mende U; Semsarian C; Martins DC; Kagen A; Duffy C; Schoen FJ; Neer EJ
    J Mol Cell Cardiol; 2001 Aug; 33(8):1477-91. PubMed ID: 11448136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A polymerase chain reaction screening strategy for the promoter of the canine dystrophin gene.
    Schatzberg S; Olby N; Steingold S; Keene B; Atkins C; Meurs K; Solomon G; Goedegebuure SA; Wilton S; Sharp N
    Am J Vet Res; 1999 Sep; 60(9):1040-6. PubMed ID: 10490068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-linked dilated cardiomyopathy. Novel mutation of the dystrophin gene.
    Franz WM; Cremer M; Herrmann R; Grünig E; Fogel W; Scheffold T; Goebel HH; Kircheisen R; Kübler W; Voit T
    Ann N Y Acad Sci; 1995 Mar; 752():470-91. PubMed ID: 7755293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy.
    Vatta M; Stetson SJ; Perez-Verdia A; Entman ML; Noon GP; Torre-Amione G; Bowles NE; Towbin JA
    Lancet; 2002 Mar; 359(9310):936-41. PubMed ID: 11918913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myosin light chain gene expression associated with disease states of the human heart.
    Trahair T; Yeoh T; Cartmill T; Keogh A; Spratt P; Chang V; dos Remedios CG; Gunning P
    J Mol Cell Cardiol; 1993 May; 25(5):577-85. PubMed ID: 8377217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting.
    Latif N; Baker CS; Dunn MJ; Rose ML; Brady P; Yacoub MH
    J Am Coll Cardiol; 1993 Nov; 22(5):1378-84. PubMed ID: 7901255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in fine structures of myofibrils and structural proteins in patients with dilated cardiomyopathy--studies with biopsied heart tissues.
    Katagiri T; Kitsu T; Akiyama K; Takeyama Y; Niitani H
    Jpn Circ J; 1987 Jun; 51(6):682-8. PubMed ID: 2959803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chamber-specific expression of human myocardial proteins detected by two-dimensional gel electrophoresis.
    Pleissner KP; Regitz-Zagrosek V; Weise C; Neuss M; Krüdewagen B; Söding P; Buchner K; Hucho F; Hildebrandt A; Fleck E
    Electrophoresis; 1995 May; 16(5):841-50. PubMed ID: 7588573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal and smooth muscle alpha-actin mRNA in endomyocardial biopsy samples of dilated cardiomyopathy patients.
    Adachi S; Ito H; Tamamori M; Tanaka M; Marumo F; Hiroe M
    Life Sci; 1998; 63(20):1779-91. PubMed ID: 9820122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of apoptotic markers in human end-stage heart failure.
    Bott-Flügel L; Weig HJ; Uhlein H; Nabauer M; Laugwitz KL; Seyfarth M
    Eur J Heart Fail; 2008 Feb; 10(2):129-32. PubMed ID: 18279768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.